• NYC UES Office
  • 970 Park Avenue, Suite GFN,
    New York, NY 10028
  • Southampton Office
  • 491 Hampton Road,
    Southampton NY 11968
  • Carnegie hill Office
  • 1175 park avenue,
    new york, ny 10128

Did you know that Park Avenue Oral & Facial Surgery now offers the latest COVID-19 antibody tests?

Schedule your Spike Protein or Nucleocapsid Protein antibody test today!

Park Avenue Oral & Facial Surgery is pleased to offer the Spike Protein and Nucleocapsid Protein antibody tests in the convenience of our office. These tests will help your healthcare provider make informed recommendations about your care and help limit the spread of COVID-19 to your family and others in your community.

The Spike Protein Antibody Test
The Spike Protein Antibody Test potentially identifies antibodies created by you in response to vaccination against the COVID-19 virus. It can also detect antibodies made in response to a COVID-19 infection. The Spike Protein antibody is one of the two distinct antibodies that bind to various components of the COVID-19 virus.

Who is a candidate for the Spike Protein Antibody Test?
The Spike Protein Antibody Test is typically used for those individuals who have taken the vaccine. One should wait at least two weeks after their second dose of the Pfizer or Moderna vaccine or after the single dose of the Johnson & Johnson vaccine in order to have antibody levels checked.

How is the Spike Protein Antibody Test administered and what is the turnaround time?
The test is administered via a blood sample and results take one to two days.

Is the test covered under the CARES Act?
Yes, the Spike Protein Antibody Test is currently covered under the CARES Act, which states that all health plans must provide coverage without applying any cost sharing to the patient.

The Nucleocapsid Protein Antibody Test
The Nucleocapsid Protein Antibody Test is designed to detect antibodies against the virus that causes COVID-19. This test detects immuglobulin G (IgG) antibodies that develop in most patients within seven to ten days after symptoms of COVID-19 begin. IgG antibodies remain in the blood after an infection has passed and indicate if you may have developed antibodies that may protect you from future infection. However, it is unknown at this point exactly how much protection antibodies might provide against another infection.

Who is a candidate for the Nucleocapsid Protein Antibody Test?
As the first antibody test developed for COVID-19, the Nucleocapsid Antibody Test potentially identifies antibodies created by you in response to an infection in order to fight the COVID-19 virus. Unlike the Spike Protein Antibody Test, it does NOT test for antibodies made in response to the COVID-19 vaccination.

This test may be administered if your healthcare provider believes you might have been exposed to the virus that causes COVID-19 based on your current or previous signs and symptoms (i.e. fever, cough, difficulty breathing, etc.). Other reasons for the test may be:
• You live in or have recently traveled to a place where transmission of COVID-19 is known to occur.
• You’ve been in close contact with an individual suspected of or confirmed to have COVID-19.
• You’ve recovered from COVID-19.

How is the Nucleocapsid Protein Antibody Test administered and what is the turnaround time?
Like the Spike Protein Antibody Test, the Nucleocapsid Protein Antibody Test is administered via a blood sample and results take one to two days.

Is the test covered under the CARES Act?
Yes, the Nucleocapsid Protein Antibody Test is also currently covered under the CARES Act.
Schedule your antibody test at Park Avenue Oral & Facial Surgery today
In order to schedule either antibody test, dependent on your circumstances, call Park Avenue Oral & Facial Surgery today. As always, we’re available to answer any questions you may have.